Great write up kpax - it's very good timing as we head into MND trial kickoff to be reminded of the science. After all, it's ultimately what we're invested in!
It seems that as the collective knowledge around neurodegenerative diseases expands, the evidence implicating mTOR and its role in up and down regulating cellular metabolism and autophagy continues to strengthen.
I would not be at all surprised to find MPL has efficacy in more than one neurodegenerative disease - Parkinson's looks like a decent candidate, as does muscular dystrophy.
Roll on MND trial commencement and some evidence of efficacy - that vital proof of concept.
Cheers
Densy
- Forums
- ASX - By Stock
- PAA
- MND Phase 1/2/3 Trial review what to expect. The Chemistry !
MND Phase 1/2/3 Trial review what to expect. The Chemistry !, page-2
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 17.0¢ | $94.51K | 540.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 262452 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 253126 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 262452 | 0.170 |
10 | 190400 | 0.165 |
6 | 141500 | 0.160 |
4 | 512800 | 0.155 |
10 | 378999 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 253126 | 6 |
0.185 | 264496 | 4 |
0.190 | 268528 | 5 |
0.195 | 233327 | 5 |
0.200 | 1144778 | 15 |
Last trade - 12.25pm 15/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online